Does this help? From the FDA SSED, June 2021 expanded use approval
Results from the retrospective study provide sufficient initial evidence to support a 6-month shelf life for the RECELL® Device (based on available stability data provided for the activity of the Enzyme component). A prospective study assessing Enzyme stability will be performed to support future extension of the current 18-month shelf-life.
- Forums
- ASX - By Stock
- Ann: Quarterly Financial Report (Form 10-Q)
Does this help? From the FDA SSED, June 2021 expanded use...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.78 |
Change
0.280(11.2%) |
Mkt cap ! $190.5M |
Open | High | Low | Value | Volume |
$2.51 | $2.80 | $2.51 | $1.286M | 482.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 934 | $2.76 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.78 | 2694 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2672 | 2.740 |
2 | 4160 | 2.730 |
4 | 12762 | 2.720 |
3 | 33966 | 2.710 |
4 | 33231 | 2.700 |
Price($) | Vol. | No. |
---|---|---|
2.760 | 4480 | 4 |
2.770 | 1700 | 2 |
2.780 | 650 | 1 |
2.790 | 3563 | 2 |
2.800 | 5449 | 3 |
Last trade - 11.45am 09/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |